Table 3. ADME Predictions of the Test Compounds Computed by SwissADME and PreADMETa.
| absorption |
distribution |
metabolism |
excretion |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GI ABS | log Kp cm/s | P-gp substrate | BBB permeability (logBB) | log VD (L/kg) | CYP3A4 inhibitor | CYP2D6 inhibitor | CYP2C9 inhibitor | CYP2C19 inhibitor | CYP1A2 inhibitor | TC (log mL/min/kg) | OCT2 substrate | |
| 1 | low | –2.36 | yes | 0.769 | 0.261 | no | no | yes | no | no | 1.588 | no |
| 2 | low | –1.65 | no | 0.815 | 0.293 | no | no | no | no | yes | 1.989 | no |
| 3 | high | –3.09 | no | –0.552 | –0.06 | yes | no | no | no | yes | 2.008 | no |
| 4 | high | –5.39 | yes | –0.2 | –0.235 | no | yes | no | no | no | 1.763 | no |
| 5 | high | –5.84 | no | –0.724 | –0.044 | yes | yes | yes | no | yes | 0.764 | no |
| 6 | high | –5.28 | no | 0.675 | 0.182 | no | no | no | no | no | 0.459 | no |
| 7 | low | –1.28 | yes | –0.939 | –1.293 | yes | no | no | no | no | 0.722 | no |
| 8 | low | –2.42 | yes | –0.995 | –0.067 | no | no | no | no | no | 1.875 | no |
| 9 | high | –6.49 | no | –0.309 | –0.014 | no | no | no | no | yes | 0.768 | no |
| 10 | high | –6.69 | no | –0.456 | –0.229 | no | no | no | no | yes | 0.876 | no |
| 11 | low | 0.71 | yes | –0.617 | –0.854 | no | no | no | no | no | 0.748 | no |
| 12 | high | –5.51 | no | 0.008 | –0.101 | no | no | no | yes | yes | 0.837 | no |
| CPFX | high | –9.09 | yes | –0.425 | –0.17 | no | no | no | no | no | 0.633 | no |
GI = gastro-intestinal, ABS = absorption, BBB = blood–brain barrier, P-gp = P-glycoprotein, and CYP = cytochrome-P.